Development and validation of stability indicating RP-HPLC method for estimation of pitavastatin calcium in bulk and tablet dosage form (Record no. 10879)

000 -LEADER
fixed length control field a
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20200110121757.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200110b xxu||||| |||| 00| 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency AIKTC-KRRC
Transcribing agency AIKTC-KRRC
100 ## - MAIN ENTRY--PERSONAL NAME
9 (RLIN) 11643
Author Suhagia, B. N.
245 ## - TITLE STATEMENT
Title Development and validation of stability indicating RP-HPLC method for estimation of pitavastatin calcium in bulk and tablet dosage form
250 ## - EDITION STATEMENT
Volume, Issue number Vol.56(2), Feb
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Mumbai
Name of publisher, distributor, etc. Indian Drug Manufacture's Association - IDMA
Year 2019
300 ## - PHYSICAL DESCRIPTION
Pagination 47-56p.
520 ## - SUMMARY, ETC.
Summary, etc. An isocratic stability-indicating reverse phase high performance liquid chromatographic diode array detection method has been developed and validated for the quantitative determination of pitavastatin calcium in the presence of its degradation products. The chromatographic separation was achieved on Phenomenex Luna C18 column (250 X 4.0 mm id, 5μm) in the isocratic mode using acetonitrilemethanol- water (35:25:40, v/v/v, pH 3 adjusted with orthophosphoric acid) as mobile phase. The drug is subjected to different accelerated stress conditions and peaks of the degradation products were well resolved from the pure drug, which indicates the specificity and stability-indicating properties of the method. The method was linear (r= 0.9998) over the concentration range of 5-30 μg/mL. The proposed method was used to investigate the degradation kinetics of PTV in acidic condition at different temperatures. Degradation of pitavastatin followed first-order kinetics, and rate constant (k), half life (t1/2), time left for 90% potency (t90) and energy of activation were calculated.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
9 (RLIN) 4639
Topical term or geographic name entry element PHARMACEUTICS
700 ## - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 11644
Co-Author Akabari, A. H.
773 0# - HOST ITEM ENTRY
Place, publisher, and date of publication Mumbai Indian Drug Manufactures Association
Title Indian drugs
856 ## - ELECTRONIC LOCATION AND ACCESS
URL https://www.indiandrugsonline.org/issuesarticle-details?id=ODk4
Link text Click here
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Koha item type Articles Abstract Database
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Permanent Location Current Location Shelving location Date acquired Barcode Date last seen Price effective from Koha item type
          School of Pharmacy School of Pharmacy Archieval Section 2020-01-10 2020662 2020-01-10 2020-01-10 Articles Abstract Database
Unique Visitors hit counter Total Page Views free counter
Implemented and Maintained by AIKTC-KRRC (Central Library).
For any Suggestions/Query Contact to library or Email: librarian@aiktc.ac.in | Ph:+91 22 27481247
Website/OPAC best viewed in Mozilla Browser in 1366X768 Resolution.

Powered by Koha